Introduction
As the shift towards translational research continues, the pharmaceutical industry is accelerating its spending on business intelligence (BI). This Datamonitor report forecasts and analyzes the IT opportunity for vendors serving the Big Pharma and Biotech segments. Analysis includes industry and technology trends, market forecast, and forecast by technology, geography and end-user segments.
Reasons to Purchase
- Monitor shifts in IT investments that pharmaceutical organizations are making
- Identify the most promising sub-segments of the pharmaceutical industry for your company’s offerings
- Understand high-level shifts and implications in the Big Pharma and Biotech segments
Other selected research from the 'Business Development' category:
Deals and alliances in autoimmune and inflammatory diseases
Partneringreview 2006 Vol 6 Ch 7: Bioinformatics (PR06V6C07)
Other selected research from the 'Markets' category:
Pharma Market Forecast: Anti-dyslipidemics to 2011
Designed to accompany Datamonitor`s Commercial Insight: Anti-dyslipidemics report, Pharma Market Forecast Anti-dyslipidemics presents Datamonitor forecasts for this market to 2011 and allows the user to alter key market events and their impact on order to forecast alternative scenarios Learn More
OTC Pharmaceuticals in the United Kingdom
OTC Pharmaceuticals in the United Kingdom industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. Learn More